Abeona Therapeutics (ABEO) EBIT (2011 - 2026)
Abeona Therapeutics' (ABEO) quarterly EBIT came in at -$23.0 million in Q1 2026, down 16.76% year-on-year from -$27.7 million in Q1 2025, and down 0.53% quarter-over-quarter from -$22.9 million in Q4 2025.
Abeona Therapeutics (ABEO) EBIT (2011 - 2026) Analysis & Trends
Abeona Therapeutics' EBIT history runs 16 years deep, the most recent figure standing at -$23.0 million for Q1 2026.
- On a quarterly basis, EBIT fell 16.76% year-over-year to -$23.0 million in Q1 2026; TTM through Mar 2026 was -$92.8 million, a 33.25% decrease from a year earlier, with the FY2025 full-year figure at -$89.4 million, down 39.3% from the prior year.
- EBIT eased to -$23.0 million in Q1 2026 per ABEO's latest filing, from -$22.9 million in the prior quarter.
- Across five years, EBIT topped out at -$8.0 million in Q2 2022 and bottomed at -$24.0 million in Q3 2025.
- The 5-year median for EBIT is -$15.3 million (2024), against an average of -$16.2 million.
- Across the five-year window, EBIT soared 72.27% in 2022 and tumbled 69.26% in 2024, its largest moves.
- Year by year, EBIT stood at -$12.9 million in 2022, then declined by 2.11% to -$13.2 million in 2023, then declined by 26.22% to -$16.7 million in 2024, then sank by 37.42% to -$22.9 million in 2025, then slipped by 0.53% to -$23.0 million in 2026.
- Per Business Quant, the three latest ABEO EBIT figures stand at -$23.0 million (Q1 2026), -$22.9 million (Q4 2025), and -$24.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Abeona Therapeutics | 342.84 Mn | 174.57 Mn | 6.02 Mn | -23.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.03 Mn |
| Dec 31, 2025 | -22.91 Mn |
| Sep 30, 2025 | -24.02 Mn |
| Jun 30, 2025 | -22.79 Mn |
| Mar 31, 2025 | -19.73 Mn |
| Dec 31, 2024 | -16.67 Mn |
| Sep 30, 2024 | -15.35 Mn |
| Jun 30, 2024 | -17.86 Mn |
| Mar 31, 2024 | -14.33 Mn |
| Dec 31, 2023 | -13.21 Mn |
| Sep 30, 2023 | -11.33 Mn |
| Jun 30, 2023 | -10.55 Mn |
| Mar 31, 2023 | -12.04 Mn |
| Dec 31, 2022 | -12.94 Mn |
| Sep 30, 2022 | -9.38 Mn |
| Jun 30, 2022 | -8.01 Mn |
| Mar 31, 2022 | -20.59 Mn |
| Dec 31, 2021 | -46.65 Mn |
| Sep 30, 2021 | -14.87 Mn |
| Jun 30, 2021 | -13.72 Mn |